Nonalcoholic fatty liver disease and metabolic syndrome in hypopituitary patients

American Journal of the Medical Sciences

Volumn 338, Issue 3, 2009, Pages 190-195

  Nyenwe, Ebenezer A ^a   Williamson Baddorf, Sarah ^a   Waters, Bradford ^a   Wan, Jim Y ^a   Solomon, Solomon S ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular risk; Insulin resistance; Metabolic syndrome

Indexed keywords

AMINOTRANSFERASE; CORTICOSTEROID; GLUCOSE; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE;

AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERBILIRUBINEMIA; HYPERTENSION; HYPOALBUMINEMIA; HYPOPITUITARISM; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; RACE DIFFERENCE; COHORT ANALYSIS; FATTY LIVER; MIDDLE AGED; UNITED STATES;

AGED; COHORT STUDIES; FATTY LIVER; FEMALE; HUMANS; HYPOPITUITARISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; TENNESSEE;

EID: 70349234674     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181a84bde     Document Type: Article

References (33)

1. Hew FL, Koschmann M, Christopher M, et al. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 1996;81:555-564 (Pubitemid 26055663)
2. Johansson J, Fowelin J, Landin K, et al. Growth hormone-deficient adults are insulin resistant. Metabolism 1995;44:1126-1129 (Pubitemid 26084031)
3. Srinivasan S, Ogle GD, Garnett SP, et al. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 2004;89:81-86 (Pubitemid 38183863)
4. Johannsson G, Bengtsson BA. Growth hormone and the metabolic syndrome. J Endocrinol Invest 1999;22(suppl 5):41-46
5. Ichikawa T, Hamasaki K, Ishikawa H, et al. Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency. Gut 2003;52:914. (Pubitemid 36613507)
6. Adams LA, Feldstein A, Lindor KD, et al. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 2004;39:909-914 (Pubitemid 38428928)
7. Rose T, Bengstsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288
8. Bülow B, Hagmar L, Mikoczy Z, et al. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf) 1997; 46:75-81. (Pubitemid 27072849)
9. Bates AS, Van't Hoff W, Jones PJ, et al. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996;81:1169-1172
10. Bates A, Bullivant B, Sheppard M, et al. Life expectancy following surgery for pituitary tumours. Clin Endocrinol (Oxford) 1999;50: 315-319 (Pubitemid 29166710)
11. Tomlinson J, Holden N, Hills R, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001;357:425-431
12. Svensson J, Bengtsson B, Rosen T, et al. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab 2004;89:3306-3312 (Pubitemid 38960692)
13. Takano S, Kanzaki S, Sato M, et al. Effect of growth hormone on fatty liver in panhypopituitarism. Arch Dis Child 1997;76:537-538 (Pubitemid 27334727)
14. Jonas MM, Krawczck LE, Kim HB, et al. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome. Liver Transpl 2005; 11:108-110
15. Nakajima K, Hashimoto E, Kaneda H, et al. Pediatric nonalcoholic steatohepatitis associated with hypopituitarism. J Gastroenterol 2005; 40:312-315 (Pubitemid 40613391)
16. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-1214
17. Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998;83:382-395
18. Shankar TP, Fredi JL, Himmelstein S, et al. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver. Am J Med Sci 1986;291:248-254 (Pubitemid 17049575)
19. Shankar TP, Solomon SS, Duckworth WC, et al. Growth hormone and carbohydrate intolerance in cirrhosis. Horm Metab Res 1988;20: 579-583
20. Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-1351
21. Charro A, Considine RV, Senaris R, et al. Regulation of growth hormone secretion by leptine. In: Beck-Peccoz EP, editor. Regulation of pituitary hormone secretion. Bristol: BioScientifica Ltd; 1999. p. 181-189
22. Farooqi IS, O'Rahilly S. Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract Endocrinol Metab 2008;4:569-577
23. Mersbach H, Svendsen OL, Holst JJ, et al. Comparisons of leptin, incretins, and body composition in obese and lean patients with hypopituitarism and healthy individuals. Clin Endocrinol (Oxf) 2003;58:65-71.
24. Ozby N, Algun E, Turgut AS, et al. Serum lipid and leptin concentration in hypopituitary patients with growth hormone deficiency. Int J Obes Relat Disord 2000;24:619-626 (Pubitemid 30323495)
25. al-Shoumer KA, Anyaoku V, Richmond W, et al. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxford) 1997;47:153-159
26. Myers MG, Cowley MA, Münzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 2008;70:537-556
27. O'Rahilly S. Genetic defects causing severe early-onset obesity. In: Beck-Peccoz EP, editor. Regulation of pituitary hormone secretion. Bristol: BioScientifica Ltd; 1999;139-148
28. Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab 2002;16: 623-637
29. Crespo J, Rivero M, Fabrega E, et al. Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig Dis Sci 2002;47:1604-1610 (Pubitemid 34753942)
30. Sahai A, Malladi P, Pan X, et al. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 2004;287:1035-1043 (Pubitemid 39423696)
31. Bullo M, Garci-Lorda P, Megias I, et al. Systemic inflammatory, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003;11:525-531 (Pubitemid 41202413)
32. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274:1185-1188
33. Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-591 (Pubitemid 351214285)